Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT107 in Resistant Hepatitis C Genotype 1
NCT01025596Phase 2Completed
- Sponsor
- Cytheris SA
- Start
- May 2007
- Primary completion
- Feb 2011
- Modality
- Cytokines & Interferons
- Countries
- 3
01
Overview
A Phase 2 trial of recombinant human interleukin-7 in hepatitis C (HCV), sponsored by Cytheris SA. Started May 2007; status: completed.
02
Drugs
recombinant human interleukin-7
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01025596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025596.